What top creators are saying about Molina Healthcare Inc.(MOH)

Mentioned as among the healthcare stocks holding up better during the selloff.

Faces Medicaid attrition risk where the remaining pool of insured members is sicker, posing a risk to future earnings.

The regulatory re-rating provides a fundamental floor for value-based healthcare providers.

Suffering from Medicaid redetermination crisis and sicker patient base; analyst suggests waiting until mid-2027 for a potential entry point.

Reported 'disastrous' results, missing expectations 'everywhere' with a 'terrible' earnings trajectory. 2025 earnings are expected to be down 51%.

Part of the worst-performing healthcare subsector (medical insurance) due to higher-than-expected cost increases; the stock was down 42%.

Stock was down 4% due to the delayed vote on extending ACA subsidies, creating a short-term headwind for the sector.

Reported 'awful' results, missing earnings by a wide margin and drastically reducing its 2025 earnings guidance by 26%. The stock fell 20% on the news.

A bullish short-term signal was generated by the speaker's quantitative trading tool, indicating a short-term trade opportunity.

Stock is down significantly (in the 40% to 53% range) due to 'absolute carnage' in the managed care sector from rising healthcare costs.

Identified as a clear loser from the new bill, which includes major cuts to Medicaid, directly threatening the company's revenue and growth prospects.

Could be negatively impacted by a reduction in Medicaid enrollees if eligibility rules are tightened, representing a direct headwind to revenue.